JP2005515192A5 - - Google Patents

Download PDF

Info

Publication number
JP2005515192A5
JP2005515192A5 JP2003546928A JP2003546928A JP2005515192A5 JP 2005515192 A5 JP2005515192 A5 JP 2005515192A5 JP 2003546928 A JP2003546928 A JP 2003546928A JP 2003546928 A JP2003546928 A JP 2003546928A JP 2005515192 A5 JP2005515192 A5 JP 2005515192A5
Authority
JP
Japan
Prior art keywords
ecacc
ddm
cell line
melanoma cell
heterogeneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003546928A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2002/000802 external-priority patent/WO2003045427A2/en
Publication of JP2005515192A publication Critical patent/JP2005515192A/ja
Publication of JP2005515192A5 publication Critical patent/JP2005515192A5/ja
Pending legal-status Critical Current

Links

JP2003546928A 2001-11-29 2002-11-29 ヒト又は動物において免疫応答を誘導するための医薬組成物 Pending JP2005515192A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101770 2001-11-29
US33670601P 2001-12-07 2001-12-07
PCT/DK2002/000802 WO2003045427A2 (en) 2001-11-29 2002-11-29 Pharmaceutical composition for inducing an immune response in a human or animal

Publications (2)

Publication Number Publication Date
JP2005515192A JP2005515192A (ja) 2005-05-26
JP2005515192A5 true JP2005515192A5 (https=) 2006-01-05

Family

ID=26069102

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003546928A Pending JP2005515192A (ja) 2001-11-29 2002-11-29 ヒト又は動物において免疫応答を誘導するための医薬組成物

Country Status (11)

Country Link
US (2) US7771998B2 (https=)
EP (1) EP1448229B1 (https=)
JP (1) JP2005515192A (https=)
AT (1) ATE446106T1 (https=)
AU (1) AU2002365291B2 (https=)
DE (1) DE60234115D1 (https=)
DK (1) DK1448229T3 (https=)
ES (1) ES2335396T3 (https=)
IL (1) IL161832A0 (https=)
RU (1) RU2313365C2 (https=)
WO (1) WO2003045427A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ755300A0 (en) 2000-05-17 2000-06-08 Monash University Immune potentiating compositions
DE10112851C1 (de) * 2001-03-16 2002-10-10 Gsf Forschungszentrum Umwelt Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
EP1565577B1 (en) * 2002-11-28 2007-09-19 Peter Kufer Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts
EP1820856B1 (en) * 2004-11-18 2011-04-27 National University of Corporation Hiroshima University Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
EP1996614A1 (en) 2006-01-30 2008-12-03 The Ludwig Institute for Cancer Research Ctsp cancer-testis antigens
GB0612342D0 (en) * 2006-06-21 2006-08-02 Glaxosmithkline Biolog Sa Method
GB0700284D0 (en) * 2007-01-08 2007-02-14 Glaxosmithkline Biolog Sa Combination therapy
EP2154243B1 (en) * 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell
JP2011529080A (ja) * 2008-07-24 2011-12-01 ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド 癌幹細胞を標的とする治療法
CN102575227A (zh) * 2008-10-08 2012-07-11 英特瑞克斯顿股份有限公司 表达多种免疫调节剂的工程改造细胞及其应用
EP3101122B1 (en) 2009-08-24 2023-06-14 Baylor College of Medicine Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
CA2794196A1 (en) * 2010-03-23 2011-09-29 Intrexon Corporation Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
GB201013443D0 (en) * 2010-08-11 2010-09-22 Cytovac As Compositions and methods for producing dendritic cells
EP2750768B1 (en) 2011-08-30 2018-10-03 Astex Pharmaceuticals, Inc. Decitabine derivative formulations
AU2012325758A1 (en) * 2011-10-20 2014-04-24 Neostem Oncology, Llc Antigen presenting cancer vaccine with gamma interferon
JP5871228B2 (ja) * 2011-10-31 2016-03-01 国立大学法人佐賀大学 慢性副鼻腔炎の検出方法
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
PT2812431T (pt) 2012-02-09 2019-10-18 Baylor College Medicine Pepmixes para gerar ctls multivirais com larga especifidade
WO2014007669A1 (ru) * 2012-07-04 2014-01-09 Volgushev Sergei Anatolievich Аутологичная клеточная вакцина для лечения онкологических заболеваний и способ ее получения
AU2016287585B2 (en) 2015-07-02 2020-12-17 Otsuka Pharmaceutical Co., Ltd. Lyophilized pharmaceutical compositions
JP6999941B2 (ja) 2015-09-18 2022-02-10 ベイラー カレッジ オブ メディスン 病原体からの免疫原性抗原同定および臨床的有効性との相関
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
KR20200035438A (ko) 2017-08-03 2020-04-03 오쓰까 세이야꾸 가부시키가이샤 약물 화합물 및 이의 정제 방법
EA202190267A1 (ru) 2018-07-15 2021-05-17 Инокиан Байофарма, Инк. Способы и композиции с использованием рекомбинантных дендритных клеток для терапии рака
EP3903811A1 (en) 2020-05-01 2021-11-03 R.G.C.C. Holdings AG Pharmaceutical composition and method for inducing an immune response
EP3981425A1 (en) 2020-10-12 2022-04-13 R.G.C.C. Holdings AG Sars-cov-2 vaccines
CA3119597C (en) 2020-10-12 2023-07-11 R.G.C.C. Holdings AG Sars-cov-2 vaccines

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
AU2087401A (en) * 1999-12-10 2001-06-18 Epimmune, Inc. Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
US20040241176A1 (en) 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
AU2002252268B2 (en) 2001-03-09 2007-01-18 Baylor Research Institute Method of treating malignancies through induction of blood immune responses

Similar Documents

Publication Publication Date Title
JP2005515192A5 (https=)
WO2004022709A3 (en) Epitope sequences
WO2002081646A3 (en) Epitope sequences
JP2014012738A (ja) 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
JP2006526414A5 (https=)
JP2000276471A5 (https=)
JP2007508573A5 (https=)
ATE384785T1 (de) Herstellung von viren, virusisolaten, und impfstoffen
DK1448229T3 (da) Farmaceutisk sammensætning til at inducere et immunrespons hos et menneske eller et dyr
JP2011152135A5 (https=)
WO2004094473A3 (en) Humanized antibodies to interferon alpha receptor-1 (ifnar-1)
JP2022501055A5 (https=)
NO954318L (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
AU2003240631A8 (en) A t cell subpopulation regulating gut immunity
Saiku et al. Microleakage of a dental amalgam alloy bonding agent.
NO20033967L (no) Fremgangsmåte for fremstilling av mikropartikler som inneholder metoprolol
WO2004070950A3 (en) Device for encoding a video data stream
Berry et al. Microleakage of amalgam restorations using dentin bonding system primers.
BR0313150A (pt) Cápsulas de gelatina que exibem ligação reticulada reduzida
Martynov The shell collection of JH Chemnitz in the Zoological Institute RAN
JP2020125362A5 (https=)
SE0302794D0 (sv) Novel microparticles for ultrasound contrast imaging and drug delivery
DE60335139D1 (de) Virusähnliche partikel, verfahren zur herstellung und immunogene zusammensetzungen
WO2003095491A3 (en) Antibody screening libraries
JP2020129755A5 (ja) 画像処理装置及び方法、及び撮像装置